openPR Logo
Press release

Herpes Marker Testing Market Explores New Growth Opportunities By 2023

05-05-2017 04:03 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Herpes Marker Testing Market Explores New Growth Opportunities

Herpes virus is a ubiquitous pathogen whose primary infections are usually asymptomatic. There are two types of Herpes Simplex virus (HSV): HSV-1 is known to cause orofacial disease such as cold sores; while HSV-2 causes genital infections. Over 80% of the herpes infections are asymptomatic; symptomatic infections are presented with blistering sores, pain during urination, swollen lymph nodes, and fever. Period of latency and mode of reactivation of HSV is yet unclear.

This Report Gives Readers a Comprehensive Overview of Herpes Marker Testing Market: http://www.transparencymarketresearch.com/herpes-marker-testing-market.html

Herpes Simplex is a highly contagious virus which is passes through direct contact with infected patients. The virus is transferred through body fluids such as saliva, blood and semen. Some studies have also shown that the virus can be transferred through breast milk. HSV infection is also common in patients with compromised immune system. Thus transplant patients and human immunodeficiency virus (HIV) positive patients are at higher risk of acquiring HSV infections. Since majority of HSV infections are asymptomatic, physicians are dependent on diagnostic tests for accurate diagnosis and treatment. Currently, there are four types of tests available for HSV biomarker testing; these include cell culture tests, antigen tests, antibody tests, and polymerase chain reaction (PCR) tests. In cell culture tests, specimens from the skin lesions or blisters are taken to develop viral cultures. Although the test is more accurate, it is time consuming and may give false negative results if lesions are in process of healing. Antigen and antibody tests are enzyme linked Immunosorbent assay (ELISA) based tests and are the most widely used tests globally. Blood samples are usually tested for HSV antigens and antibodies. These rapid tests provide quick and accurate results, which helps in further diagnosis and treatments. PCR tests have been the most accurate tests used for HSV diagnosis. The test can also differentiate between HSV-1 and HSV-2 viral load.

According to prevalence statistics published by Centers for Disease Control and Prevention (CDC), HSV-2 prevalence was found to be over 16% in the U.S. citizens and mainly affected African-America female population. Public Health Agency of Canada mentions that prevalence of HSV-1 infection is greater than HSV-2 infections is most of the geographical regions. The data also shows that HSV-1 seroprevalence in adults in over 70% in developed countries, while almost 100% in developing and underdeveloped countries. Various publications also show that prevalence of HIV is higher in low and middle income countries. Thus it is expected that the prevalence of herpes simplex virus would remain high in these countries. Due to under developed economic conditions, cost effective diagnosed tests are in high demand. In spite of these conditions, North America and Europe lead the market owing to higher seroprevalence, and large number of transplant and HIV patients.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Herpes Marker Testing Market by 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5510

In 2014, U.S. FDA approved Quest Diagnostics, Inc’s HSV diagnostic test Simplexa HSV 1 and 2 direct molecular test on the 3M Integrated Cycler. The Simplexa test is the first molecular test that has been approved by the U.S. FDA, that enables qualitative detection as well as differentiation of HSV-1 and HSV-2 in cerebrospinal fluid (CSF). Other diagnostic tests in the market include Capita IgG test by Trinity Biotech, IsoAmp HSV Assay by Biohelix and HerpeSelect by Focus Diagnostics. Some of the key players in the global herpes marker testing market include DiaSorin, Roche, Enzo Life Sciences and Thermo Fisher Scientific.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Herpes Marker Testing Market Explores New Growth Opportunities By 2023 here

News-ID: 525685 • Views: 274

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for HSV

Herpes Simplex Virus (HSV) Vaccines Market - Sanofi S.A., GlaxoSmithKline Plc., …
Global Herpes Simplex Virus (HSV) Vaccines Market: The report provides a valuable source of insightful data for business strategists and competitive analysis of Herpes Simplex Virus (HSV) Vaccines Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market
How to meet and Date Gay HSV Singles?
In movies, finding the right date seems so easy. But that's far away from the truth. After all, there are so many things that you need to do for finding the right person. Sometimes you might be even feeling frustrated for not finding any right gay HSV singles no matter how hard you tried. But don't worry, finding the right partner is not that hard. All you need to do is
Herpes Simplex Virus (HSV) Vaccines Market - Top Players Sanofi S.A., GlaxoSmith …
The strategy analysis on Global Herpes Simplex Virus (HSV) Vaccines Market gives insights of market size, trends, share, growth, development plans, Investment Plan, cost structure and driver’s analysis. With precise data covering all key aspects of the existing market, this report offers existing data of leading manufacturers. The Herpes Simplex Virus (HSV) Vaccines Market report covers marketing channels and market positioning to potential growth strategies, providing in-depth analysis for new
Why should HSV singles take the decision of dating by own?
What does it mean when a partner tells others that he or she has herpes? On the open front, a number of thoughts will come in mind with reference to this question. It might be because he or she doesn’t want to cheat you or so. Surprisingly, you might not be ready with the apt answer. So this time, we are here to help you with the answer and enlighten
Hsvbuddies continues to be the top of the list of HSV dating
Many times HSV singles are bound to prohibit themselves under the corner, thinking of no hope around. It is for the reason of no proper resolute of herpes dating. Herpes dating sites are working towards the line, and Hsvbuddies is one of them that hold immense gratitude at the forefront. Features that make the website reliable The budgeted membership plans The pricing structure laid under the stream of the website
Global Expanded Thermoplastic Polyurethane Market Growth during the Forecast Per …
Since the expanded thermoplastic polyurethanes are in the introduction phase in the Expanded Thermoplastic Polyurethane Market, the demand for expanded thermoplastic polyurethanes is expected to rise in the coming years. Manufacturers are focused on development of expanded thermoplastic polyurethanes for newer application areas. Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2519 Properties offered by expanded thermoplastic polyurethane are a combination of the properties of thermoplastic polyurethane and foam. Expanded thermoplastic polyurethane is a highly